The Relation Between Cardiac Function and Cerebral Blood Flow in Stroke Patients.
• The effects of CO 2 inhalation were determined on 23 stroke patients with and without hypertension who underwent clinical, cardiohemodynamic, cerebral blood flow (hemispheric mean and regional), cerebral metabolic rate and cerebral angiographical studies.
Cardiac output, heart rate, systemic and pulmonary arterial blood pressures and cardiac work rose in essentially all patients during CO 2 inhalation, and fell to below baseline levels in approximately half of the patients studied after CO., inhalation was discontinued.
Baseline cardiac output was normal in normotensive stroke patients without cardiac dysfunction, but was low in hypertensive stroke patients.
A statistically significant increase in cerebral blood flow occurred during CO;, inhalation, with an observed decrease in cerebrovascular resistance. The percentage increase in cerebral blood flow exceeded the increase in cardiac output.
Since hypercarbia causes a rise in systemic and pulmonary arterial blood pressure, CO 2 inhalation should be used cautiously in patients with systemic or pulmonary hypertension. The rise in cardiac work during CO 2 inhalation could jeopardize patients with coronary heart disease and those with heart failure.
Following cessation of CO 2 inhalation, blood pressure and cardiac output may fall below baseline levels, with a risk of posthypercapnic fall in cerebral blood flow. Occasionally, cardiac arrhythmia occurs during or following CO 2 inhalation. pathogenesis of stroke. One part of this overall plan of study was to compare and evaluate the effects of CO 2 inhalation in normotensive stroke patients without cardiac dysfunction and in stroke patients with cardiovascular abnormalities.
CO 2 inhalation, which has been used by some clinicians in the treatment of stroke, is the most potent of the cerebrovascular dilators, is one of the most effective tests of cerebrovascular reactivity, and has pronounced systemic cardiovascular effects. The effects are described of COo inhalation on 23 stroke patients with and without hypertension. 
Methods
Twenty-three patients with stroke on the neurological and medical services of the Philadelphia General Hospital were studied. Nine of the patients had stroke without history or physical findings of hypertension or heart disease. Fourteen others had a history of hypertension without congestive heart failure and seven of these were hypertensive (diastolic) at the time of study. The medical and neurological diagnoses and clinical findings are listed in tables 1 and 2.
The cardiohemodynamic parameters were determined by direct measurements and by calculations. Right-sided cardiac catheterization was performed in the usual manner via an antecubital vein. Cardiac output was determined from dye dilution curves obtained by continuous recording of dye concentration with a Gilford densitometer cuvette using a Gilford computer. Blood pressure (systolic, mean and diastolic) was measured by a transducer manometer (statham strain gauge) and recorded by Electronics for Medicine Recorder. Central venous, right atrial, right ventricular, pulmonary artery and pulmonary wedge pressures were obtained. Electrocardiograms were taken through conventional limb and chest leads. Cardiac work was calculated from mean" arterial blood pressure and cardiac output; total systemic vascular resistance was calculated according to Poiseuille's law; and analyses of the blood samples for oxygen and carbon dioxide determinations by the manometric method of Van Slyke and Neil.
In each study cerebral blood flow (CBF) measurements consisted of: regional cerebral blood flow (rCBF); hemispheric mean CBF; mean arterial blood pressure (MABP); cerebral vascular resistance (CVR); arterial hemoglobin (Hb), pH, carbon dioxide tension (Pco 2 )> oxygen tension, and carbon dioxide and oxygen content; jugular venous oxygen tension and oxygen content; arteriovenous oxygen difference and cerebral metabolic rate.
To carry out cerebral blood flow measurements, the method of Lassen and Ingvar 21 ' 22 has been adapted and used by our laboratory. 28 ' 24 In brief, the rCBF study was carried out as follows: Xenon 138 in saline is injected through a catheter in the internal carotid artery. Clearance of the Xenon is monitored by eight scintillation detectors contained in a collimator block. The clearance of isotope from each brain region is recorded separately on multiple-channel magnetic tape and subsequently analyzed on the IBM 360 computer. The data in this report are given as uncorrected stochastic ten-minute hemispheric mean CBF. Regional cerebral blood flow results are to be reported elsewhere.
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Cerebral blood flow was determined before CO 2 inhalation and between the tenth and twentieth minute of CO 2 inhalation in 21 patients. Cardiac output was determined midway during each CBF determination, and blood pressures were monitored and recorded intermittently. Cerebral angiography 25 . 20 was performed by simultaneous serial frontal and lateral views in all patients.
Statistical Methods
Statistical analysis was necessary to determine if a difference existed between the normotensive and hypertensive stroke patients in the way that they responded to-CO 2 inhalation. Also, a statistical determination had to be made regarding the effect of CO 2 inhalation on all patients in reference to the nine parameters involved.
Two samples of sizes n = 9 for normotensive patients and n = 14 for hypertensive patients were examined on the bases of nine measures or variables, each having a baseline or control level. The generalized null hypothesis of no difference between the two groups was to be tested on a multivariate basis formed by the linear compound of the nine mean differences between the two samples after an adjustment for each variable had been made based on its baseline or control value. This procedure is in generalized form a one-way multivariate analysis of covariance.
Both samples were combined as one group in order to test for whether or not the inhalation of CO 2 caused an increase or decrease of the nine parameters being examined. Hotelling's T 2 test was used to test die above hypothesis, with an evaluation by Sheffe" simultaneous confidence intervals. The univariate related t tests were also done.
See the appendix for details of statistical analysis.
Results
The results are presented on the studies performed on nine normotensive stroke patients without evidence of cardiac dysfunction (table 3) , and on 14 patients with a history of hypertension but without congestive heart failure (table 4). The data are summarized in figure 1 .
The two groups of patients (nine normotensive, 14 hypertensive) reacted statistically similarly to CO 2 inhalation in most respects, and those patients who were hypertensive at the time of study. Since the response to CO 2 is the same in these two groups of patients and since the number of patients in these two groups is small, they will be discussed together. There were no significant untoward effects during the study of these patients.
NORMOTENSIVE PATIENTS
Mean systemic arterial blood pressure (MABP) rose in all nine patients during CO 2 inhalation from an average control mean of 96 to a mean of 112, a 17% increase. In one patient (BM) the MABP rose as high as 152 mm Hg (250 mm Hg systolic and 121 mm Hg diastolic) during CO 2 inhalation. There was a statistically significant rise in MABP with CO2 inhalation (statistical tables 1 and 2).
MABP determinations were made within 30 minutes after CO 2 inhalation was discontinued and demonstrated MABP below control levels in five of the seven patients.
Heart rate (HR) increased above baseline levels in all patients.
Control mean right atrial, pulmonary arterial (MPAP) and pulmonary wedge pressures were normal in all but two patients who showed borderline high values. During CO.. inhalation, the MPAP rose above control values in eight patients and in one patient (MN) it remained unchanged. Generally, MPAP returned to control levels following discontinuance of CO 2 inhalation. The rise in MPAP was statistically significant (statistical tables 1 and 2).
Baseline cardiac output was normal (cardiac index [CI] > 2.5 L/sq m/min) in eight of nine patients. It rose in all but one patient (LJ) during CO 2 inhalation (average rise 23%), and fell to below control levels in four of six patients measured following discontinuance of CO 2 . The mean fall in CI (below control levels) after discontinuance of CO 2 was 0.54 L/sq m/min, a 17% change. There was no consistent pattern of change in total systemic vascular resistance (TSVR), but cardiac work (CW) rose markedly during CO.. inhalation in all patients studied.
Hemispheric mean CBF increased above STATISTICAL control levels during CO 2 inhalation in all patients studied, rising an average of 50%, or 27% higher than the rise in cardiac output, which was statistically significant (statistical tables 1 and 2). Regional CBF (rCBF) also increased even in those areas showing zones of regional ischemia. Cerebral vascular resistance (CVR) fell in all patients during CO 2 inhalation.
HYPERTENSIVE PATIENTS
MABP rose in all patients during CO 2 inhalation. The rise in MABP was statistically significant (statistical tables 1 and 2). In one patient (EB), the MABP rose to 177 mm Hg during CO 2 inhalation, with a systolic pressure of 249 mm Hg and a diastolic pressure of 140 mm Hg. In two of six patients, MABP fell below control levels within 30 minutes after CO 2 was discontinued, and remained unchanged in one.
Heart rate rose in all but two patients (SW, LT). Transient atrial flutter occurred in one patient (HP) immediately after CO 2 was discontinued.
Seven normotensive and nine hypertensive patients had measurement of control mean right atrial pressures. All pressures were normal. However, right ventricular pressures were borderline high in four patients, and MPAP was borderline high in three patients. During CO 2 inhalation, MPAP rose in all patients, then returned to normal after CO 2 was discontinued. The rise in MPAP was statistically significant (statistical tables 1 and 2).
Control CI was below normal in 10 of 14 patients studied. It rose in all patients during CO 2 inhalation, and fell to below control levels within 30 minutes after CO 2 was discontinued in four of seven patients measured. There was no consistent pattern of change of TSVR. CW rose in all patients during CO 2 inhalation, and fell to below control levels in four of seven patients measured after CO 2 was discontinued.
Hemispheric mean CBF and regional CBF rose in all patients when measured during CO 2 inhalation. Hemispheric mean CBF rose from a mean of 33 ml/100 gm/min to a mean of 49 ml/100 gm/min, a 48% change which was statistically significant. CVR fell in all but one patient (SW) during CO 2 inhalation.
In summary, the two groups of patients (nine normotensive, 14 hypertensive) reacted Stroka, Vol. 1, Stpltmhtr-October 1970 similarly to CO 2 inhalation in most respects, though there was some difference in regard to changes in cardiac output and heart rate.
CO 2 inhalation caused a significant increase in serum P C o 2 , BP, PAP, CW and CBF and a nearly significant increase in CI and decrease in CVR in the two groups of patients. There was no significant pattern of change in TSVR during CO 2 inhalation.
Discussion

SYSTEMIC CARDIOVASCULAR EFFECTS RESULTING FROM CO, INHALATION IN NORMAL SUBJECTS
The systemic cardiovascular effects resulting from the inhalation of 5% CO 2 are exceedingly complex. The responses represent diverse effects exerted by CO 2 upon a number of bodily areas. Some actions are depressant (cerebral cortex, myocardium); in other areas, stimulation results (mesencephalic reticular formation, chemoreceptors, respiratory and vasomotor "center"). 27 The overall hemodynamic effect of CO 2 inhalation can, therefore, be clearly understood only when its individual actions in a large number of responsive areas are known. For example, increased COj tension causes a fall in contractile force and rate of contraction in isolated hearts of various mammalian species.
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" 80 This effect is thought to be caused by a fall in pH. The effect of CO 2 on blood vessels is essentially the same as on the isolated heart, i.e., it generally causes, with few exceptions, dilatation.
81
- 85 The pulmonary vessels may constrict with increased CO 2 tension, but both the cerebral 86 - 41 and coronary arteries dilate, as well as muscular and most other peripheral arteries. This latter effect produces decreased peripheral resistance and favors peripheral pooling of blood and reduced venous return. The stimulatory effect of CO 2 upon the autonomic nervous system tends to counteract the peripheral vasodilation produced by the direct action of CO 2 on peripheral vessels. Increased CO 2 tension is a powerful stimulant to both the aortic and carotid body chemoreceptors. 42 The chemoreceptors' afferent impulses resulting from this stimulation are transmitted to various subcortical areas, including probably the posterior hypothalamus and mesencephalic reticular substance, and also the "respiratory" and "vasomotor" centers of the medulla. 48 In addition, these latter areas can be directly stimulated by CO 2 . 44 The resultant increased sympathetic nervous dis-charge usually augments the rate and force of cardiac contraction and produces vasoconstriction and arterial hypertension. Thus, the autonomic nervous system actions of CO 2 tend to antagonize those it exerts directly upon the blood vessels and heart. Therefore, the direction of the final response depends on the balance between stimulating and depressing forces.
The net effects of the stimulating and depressing forces of the cardiovascular system produced by CO 2 inhalation are increased cardiac output and usually diminution 45 of calculated total peripheral resistance. During CO 2 inhalation, the cardiac output usually increases to a greater extent than mean arterial blood pressure/ 8 Thus, despite the increase in sympathetic nervous discharge produced by CO 2 , more vascular beds generally are dilated than constricted when CO 2 is inhaled. The cerebral and myocardial vascular beds, as previously mentioned, are especially dilated by CO 2 . 47 The increased cardiac output seems to be contributed to by both the sympathetic stimulating effect of CO 2 and the resulting hyperventilation accompanying CO 2 inhalation.
An interesting phenomenon associated with CO 2 inhalation is "posthypercapnic hypotension." There are a number of hypotheses regarding the cause of this phenomenon, including that of reduced sensitivity of the medullary vasomotor center, 48 plasma volume reduction, 40 myocardial depressant effect of CO 2 , B0 uneven elimination of CO 2 from the body (elimination from brain first, later from peripheral tissues because of poor vascular perfusion),* 1 '
B2
and termination of intense sympathetic nervous activity caused by CO 2 inhalation.
58 Although these several hypotheses have been advanced to explain the fall of blood pressure to below control levels after the cessation of CO 2 inhalation, the exact mechanisms involved are unproved.
Various cardiac arrhythmias, of which the most important are ventricular, can occur both during hypercarbia and during the posthypercarbia state.
2T - 16 -S4 -6fl Involved in these responses are changes of activity of the autonomic nervous system and, perhaps, ionic flux through the myocardial surface.
SYSTEMIC CARDIOVASCULAR EFFECTS RESULTING FROM CO2 INHALATION IN STROKE PATIENTS
Cardiac output and heart rate rose in all but one patient during CO 2 inhalation. Baseline cardiac output was normal in all but one of the normotensive stroke patients but was below normal in 10 of 14 hypertensive stroke patients. The cause of the low baseline cardiac output in the majority of our hypertensive stroke patients is unknown. None of the patients had evidence of congestive heart failure, though five of the 14 patients had cardiomegaly and, therefore, clinical evidence of significant cardiac abnormality. In spite of the low baseline cardiac output in the group of hypertensive-stroke patients, these patients showed cardiovascular responses to CO 2 inhalation similar to those of the group of normotensive stroke patients, i.e., with a rise in cardiac output, though there was a statistical difference between the degree of rise in the two groups of patients. The response in cardiac output with CO 2 inhalation may also be different if congestive heart failure is present.
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This study is presently under active investigation.
Mean arterial blood pressure rose in all patients during CO 2 inhalation, but did not always rise as much as cardiac output. Therefore, calculated total systemic vascular resistance rose in some patients but fell in others. Mean arterial blood pressure, on occasions, rose to alarming levels during hypercarbia. This was especially a problem in patients whose baseline blood pressure was moderately high. The danger is real of further cerebrovascular damage during CO 2 inhalation in moderately and severely hypertensive stroke patients, though none of our patients was so affected.
Cardiac work also increased in all patients during CO 2 inhalation. The resultant stress could be detrimental to patients with congestive heart failure, and would certainly be risky in patients with coronary artery disease with or without angina pectoris or myocardial infarction, old or recent.
Cardiac output, after CO 2 was discontinued, fell to below baseline levels in about onehalf of the patients studied, and systemic arterial blood pressure fell in four patients. This posthypercarbia fall in cardiac output and systemic arterial blood pressure may, of course, create problems in cerebral perfusion following discontinuance of CO 2 inhalation. This phenomenon might produce an aggravation of cerebrovascular insufficiency, though we have no documentation of such effects in our patients. Cardiac arrhythmias during and following CO 2 inhalation, as occurred in one of our patients, may also, obviously, create problems in cerebral flow.
CO 2 inhalation invariably caused a rise in pulmonary artery pressure. This phenomenon may cause a problem in patients with stroke and cor pulmonale. CO 2 inhalation should be used with great caution in such patients.
CHANGES IN CEREBRAL BLOOD FLOW RESULTING FROM CO, INHALATION IN STROKE PATIENTS
Both hemispheric and regional cerebral blood flow increased in the two groups of stroke patients studied. It was of significant interest to find that regional cerebral blood flow also increased even in those areas showing zones of regional ischemia. Regional changes in cerebral circulation in these patients are described elsewhere.
Summary
Twenty-three stroke patients, nine normotensive and 14 hypertensive, underwent clinical cardiac hemodynamic and cerebral blood flow studies before, during, and after 5% CO 2 inhalation.
Cardiac output, heart rate, systemic and pulmonary arterial blood pressures and cardiac work rose in nearly all patients during CO-, inhalation, and these parameters fell to below baseline levels in approximately half of the patients measured after CO 2 inhalation was discontinued. The effect of CO 2 inhalation on total systemic vascular resistance followed no statistically constant pattern in stroke patients.
Baseline cardiac output was normal in normotensive stroke patients without cardiac dysfunction, but was low in hypertensive stroke patients even though there was no evidence of congestive heart failure.
Cerebral blood flow increased statistically in patients during CO 2 inhalation, with an observed decrease in cerebrovascular resistance. The percentage increase in cerebral blood flow exceeded the increase in cardiac output
Since hypercarbia causes a marked and, at times, a dangerous rise in both systemic and pulmonary arterial blood pressure, CO 2 inhalation should be used with great caution in Stroke, Vol. 1, September-October 1970 patients with significant systemic or pulmonary hypertension. In addition, the high rise in cardiac work associated with 5% CO 2 inhalation could jeopardize patients with coronary heart disease and those with borderline or overt heart failure.
Following cessation of CO 2 inhalation, the systemic arterial blood pressure and cardiac output may fall to below baseline levels, initiating a risk of posthypercapnic fall in cerebral blood flow. In addition, the occasional occurrence of cardiac arrhythmia during or following CO 2 inhalation should be viewed with considerable concern when it occurs, especially in the stroke patient.
Data descriptions were obtained containing mean, standard deviations, standard errors, minima and maxima, and range for both samples separately and as a total group (see statistical table 3 for x andS.D.).
At this point checks on original data matrix validity and homogeneity of variance were accomplished. MABP and CBF were found to be a function of CVR and MABP and CI a function of CBF. Significant heterogeneity of variance was found present between the two samples in CI and CW. In view of these findings the following tentative test procedures were applicable: (1) serum P c02 , MABP, HR, MPAP, TSVR and CVR-to be tested simultaneously; (2) CBF-to be tested singly; and (3) CI and CW-to be further investigated.
CBF was to be tested in a univariate analysis of covariance, and serum P c0 .,, MABP, HR, MPAP, TSVR and CVR were to be tested by Hotelling's 1 T 2 test after covariance adjustment if the individual covariance adjustment assumptions were met, the most important of which is parallel slopes or regression coefficients in each of the two samples for all variables being considered.
Correlations and regressions were then calculated for all nine sets of control and experimental variables (see statistical table 4 ).
The correlations were tested for sample-tosample difference as opposed to the regression coefficients to give an indication of likeness because of the low numbers of observation present in each group. HR showed a significant difference between the two sample correlation statistical table 6 the vector of five adjusted mean differences was tested with Hotelling's T 2 statistic and found to be nonsignificant (see statistical table 7), thus indicating no significant difference in any of the five mean differences at a fixed probability level.
All of the univariate related t tests except for TSVR were statistically different; however, when applying Scheffe' multiple comparisons by use of simultaneous confidence intervals to control for a joint fixed type one probability error, significance was found only in serum Pcoo> MABP, CW, and CBF, with CI and CVR just appearing to include zero in the confidence interval (statistical tables 1 and 2).
It should be noted that in HR and CI the regression coefficients of experimental on control level between the two samples were found to be vastly different, thus indicating a different form of association or co-relation between control and experimental effects. In the normotensive sample a high correlation of r = 0.924 (HR) was found showing high predictability of experimental value given baseline, and in the hypertensive sample a low correlation of r = 0.352 which was not significantly different from zero, thus showing no co-relation or predictability of experimental value given baseline. In CI the normotensive correlation of r = 0.567 was not significantly different from zero, while the hypertensive sample was with an r = 0.906 showing high predictability in the hypertensive sample. 
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